Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Joachim Morrens

Datos Biográficos

ID7964577
NOMBREJoachim Morrens
NOMBRESJoachim
APELLIDOMorrens
FIRMAMORRENS J
AFILIACIONESJanssen (Belgium)
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
OBRAS COMO AUTOR2
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2023
ÍNDICE H0
  • Iceberg study

    Open Access•Albino J Oliveira-Maia, Joachim Morrens et al.•ARTICLE•Frontiers in Psychiatry•2023

    ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video

  • Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression

    Open Access•Giulio Perugi, Paola Calò et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Treatment-resistant depression (TRD) is a debilitating condition affecting 20-30% of patients with major depressive disorders (MDD). Currently, there is no established standard of care for TRD, and wide variation in the clinical approach for disease management has been documented. Real-world data could help describe TRD clinical features, disease burden, and treatment outcome and identify a potential unmet medical need. Methods: We …

Sin obras prominentes en esta página.

  • Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression

    Open Access•Giulio Perugi, Paola Calò et al.•ARTICLE•Frontiers in Psychiatry•2021

    Introduction: Treatment-resistant depression (TRD) is a debilitating condition affecting 20-30% of patients with major depressive disorders (MDD). Currently, there is no established standard of care for TRD, and wide variation in the clinical approach for disease management has been documented. Real-world data could help describe TRD clinical features, disease burden, and treatment outcome and identify a potential unmet medical need. Methods: We …

  • Iceberg study

    Open Access•Albino J Oliveira-Maia, Joachim Morrens et al.•ARTICLE•Frontiers in Psychiatry•2023

    ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video

Depression (economics (2 obras) · Internal Medicine (2 obras) · Major depressive disorder (2 obras) · Medicine (2 obras) · Treatment of Major Depression (2 obras) · Treatment-resistant depression (2 obras) · Tryptophan and brain disorders (2 obras) · Anesthesia (1 obra) · Antidepressant (1 obra) · Bipolar Disorder and Treatment (1 obra)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae